Rituximab for post-transplant recurrences of FSGS

Pediatric Transplantation

Volumn 13, Issue 2, 2009, Pages 240-243

  Bayrakci, Umut Selda ^a   Baskin, Esra ^a   Sakalli, Hale ^a   Karakayali, Hamdi ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Children; Kidney transplantation; Plasmapheresis; Relapse; Rituximab; Steroid resistant nephrotic syndrome; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CD19 ANTIBODY; CREATININE; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PODOCIN; PREDNISOLONE; RITUXIMAB; SERUM ALBUMIN; STEROID;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL VACUOLE; CREATININE BLOOD LEVEL; DRUG MEGADOSE; EDEMA; ELECTRON MICROSCOPY; FOCAL GLOMERULOSCLEROSIS; GLOMERULAR DYSFUNCTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEUTROPENIA; PLASMAPHERESIS; PROTEINURIA; RECURRENT DISEASE; REMISSION; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ANTIBODIES, MONOCLONAL; BIOPSY; CYTOKINES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PROTEINURIA; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 59449105687     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00967.x     Document Type: Article

References (22)

1. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis post transplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992 : 12 (Suppl. S258 S263.
2. Fine RN. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 2007 : 22 : 496 502.
3. Gohh RY, Yango AF, Morissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005 : 5 : 2907 2912.
4. Raafat RH, Kalia A, Travis LB, Driven SC. High-dose oral cyclosporine therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004 : 44 : 50 56.
5. Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003 : 27 : 810 814.
6. Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmapheresis and cyclophosphamide. Pediatr Nephrol 1993 : 7 : 50 54.
7. Cragg MS, Walshe CA, Ivanov AO, Glennie MJ. The biology of CD 20 and its potential as a target for mAb therapy. Curr Dir Autoimmun 2005 : 8 : 140 174.
8. Fra GP, Avanzi GC, Bartoli E. Remission of refractory lupus nephritis with a protocol including rituximab. Lupus 2003 : 12 : 783 787.
9. Benz K, Dotsch J, Rascher W, Stachel D. Change of the course of steroid dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 2004 : 19 : 794 797.
10. Karakayali FY, Ozdemir H, Kivrakdal S, Colak T, Emiroglu R, Haberal M. Recurrent glomerular diseases after renal transplantation. Transplant Proc 2006 : 38 : 470 472.
11. Hristea D, Hadaya K, Marangon N, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transplant Int 2007 : 20 : 102 105.
12. Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transplant Int 2007 : 20 : 558 562.
13. Westphal S, Hansson S, Mjörnstedt L, Mölne J, Swerkersson S, Friman S. Early recurrence of nephrotic syndrome (immunoglobulin M nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin and rituximab. Transplant Proc 2006 : 38 : 2659 2660.
14. Nozu K, Lijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M. Rituximab treatment for post transplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 2005 : 20 : 1660 1663.
15. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006 : 354 : 1961 1963.
16. Meyer TN, Thaiss F, Stahl RAK. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transplant Int 2007 : 20 : 1066 1071.
17. Nakayama M, Kamei K, Nozu K, et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 2008 : 23 : 481 485.
18. Kamar N, Faguer S, Esposito L, et al. Treatment of focal segmental glomerulosclerosis with rituximab: 2 case reports. Clin Nephrol 2007 : 67 : 250 254.
19. Marks SD, McGraw M. Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol 2007 : 22 : 158 160.
20. Yabu JM, Ho B, Scandling JD, Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008 : 8 : 222 227.
21. Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (MMF)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant 2008 : 4 : 167 171.
22. Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE. Combined T- and B-cell activation in childhood steroid sensitive nephrotic syndrome. Clin Nephrol 2003 : 60 : 242 247.